Citrus oil and MgCl2 as antibacterial and anti-inflammatory agents

Journal of Periodontology

Volumn 77, Issue 6, 2006, Pages 963-968

  Mizrahi, Boaz ^a   Shapira, Lior ^b   Domb, Abraham J ^a   Houri Haddad, Yael ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anti inflammatory agents; Antibacterial agents; Citrus; Cytokines; Magnesium salt; Periodontitis

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CITRUS OIL; CYTOKINE; HYDROCORTISONE SODIUM SUCCINATE; INTERLEUKIN 10; MAGNESIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; IN VITRO STUDY; LEUKOCYTE MIGRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; ANIMAL; CHEMISTRY; CITRUS FRUIT; DRUG COMBINATION; DRUG EFFECT; LEUKOCYTE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CITRUS; DRUG THERAPY, COMBINATION; FEMALE; INTERLEUKIN-10; LEUKOCYTES; MAGNESIUM CHLORIDE; MICE; PLANT OILS; PORPHYROMONAS GINGIVALIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747064733     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050278     Document Type: Article

References (40)

1. Page RC, Offenbacher S, Schroeder HE, et al. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216-248.
2. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63:322-331.
3. Drake DR, Chung J, Grigsby W, Wuyuan C. Synergistic effect of pyrophosphate and sodium dodecyl-sulfate on periodontal pathogens. J Periodontol 1992; 63:696-700.
4. Christersson LA, Zambon JJ, Genco RJ. Dental bacterial plaques: Nature and role in periodontal disease. J Clin Periodontol 1991;18:441-446.
5. Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria. J Periodontal Res 1996;31:393-407.
6. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodontal Res 1991;26:213-217.
7. Carter LL, Dutton RW. Type 1 and type 2: A fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996;8:336-342.
8. Mosmann TR, Coffman RL. Th1-cell and Th2-cell: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
9. Houri-Haddad Y, Soskolne WA, Halabi A, et al. Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology 2000;99:215-220.
10. Drisko CH. Nonsurgical periodontal therapy. Periodontol 2000 2001;25:77-88.
11. Jones CG. Chlorhexidine: Is it still the gold standard? Periodontol 2000 1997;15:55-62.
12. Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 1999;86:985-990.
13. Choi HS. Character impact odorants of Citrus Hallabong [(C. unshiu Marcov × C. sinensis Osbeck) × C. reticulata. Blanco] cold-pressed peel oil. J Agric Food Chem 2003;51:2687-2692.
14. de Oliveira BH, Strapasson RA. Biotransformation of the monoterpene, limonene, by Fusarium verticilloides. Braz Arch Biol Technol 2000;43:11-14.
15. Andrews RE, Parks LW, Spence KD. Some effects of Douglas-Fir terpenes on certain microorganisms. Appl Environ Microbiol 1980;40:301-304.
16. Goren AC, Bilsel G, Bilsel M, et al. Analysis of essential oil of Coridothymus capitatus (L.) and its antibacterial and antifungal activity. Zeftschrift Naturforsch Sect C J Biosci 2003;58:687-690.
17. Naigre R, Kalck P, Rogues C, et al. Comparison of antimicrobial properties of monoterpenes and their carbonylated products. Planta Med 1996;62:275-277.
18. Dead Sea Work Data release BS, Israel.
19. Schempp CM, Dittmar HC, Hummler D, et al. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro, involvement of ATPase, HLA-DR, B7 molecules, and cytokines. J Invest Dermatol 2000;115:680-686.
20. Fawcett WJ, Haxby EJ, Male DA. Magnesium: Physiology and pharmacology. Br J Anaesth 1999;83:302-320.
21. Sheu JR, Hsiao G, Shen MY, et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br J Haematol 2002;119:1033-1041.
22. Yokoyama T, Oono H, Miyamoto A, et al. Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats. Life Sci 2003;72: 1247-1257.
23. Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci 2004;93:2927-2935.
24. Shapira L, Soskolne A, Halabi A, et al. Induction of tumor necrosis factor alpha and interleukin-1 beta in subcutaneously implanted chamber by lipopolysaccharide. J Endotoxin Res 1997;4:325-329.
25. Genco CA, Arko RJ. Animal chamber models for study of host-parasite interactions. Methods Enzymol 1994;235:120-140.
26. Baker PJ, Evans RT, Roopenian DC. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 1994;39:1035-1040.
27. Frolov I, Houri-Hadad Y, Soskolne A, Shapira L. In vivo exposure to Porphyromonas gingivalis up-reguiates nitric oxide but suppresses tumour necrosis factor-alpha production by cultured macrophages. Immunology 1998;93:323-328.
28. Sikkema J, Debont JAM, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 1995;59:201-222.
29. Sikkema J, de Bont JAM, Poolman B. Interactions of cyclic hydrocarbons with biological membranes. J Biol Chem 1994;269:8022-8028.
30. Griffin SG, Wyllie SG, Markham JL, Leach DN. The role of structure and molecular properties of terpenoids in determining their antimicrobial activity. Flavour Fragrance J 1999;14:322-332.
31. Sikkema J, Poolman B, Konings WN, de Bont JAM. Effects of the membrane action of tetralin on the functional and structural properties of artificial and bacterial membranes. J Bacteriol 1992;174:2986-2992.
32. Todorovic T, Vujanovic D. The influence of magnesium on the activity of some enzymes (AST, ALT, ALP) and lead content in some tissues. Magnes Res 2002;15:173-177.
33. Gemmell E, Winning TA, Bird PS, Seymour GJ. Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model. J Periodontol 1998;69:1131-1138.
34. Hart TC, Shapira L, Van Dyke TE. Neutrophil defects as risk factors for periodontal diseases. J Periodontol 1994;65:521-529.
35. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
36. Lehr HA, Arfors KE. Mechanism of tissue damage by leukocytes. Curr Opin Hematol 1994;1:92-99.
37. Tenenbaum H, Schaaf JF, Federlin-Ducani M, et al. Clinical efficiency of a 0.1% chlorhexidine mouthwash in adult periodontitis patients. J Dent Res 2002;81: B245-B245.
38. Garrett S, Johnson L, Drisko CH, et al. Two multicenter studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 1999;70:490-503.
39. Drisko CL, Cobb CM, Killoy WJ, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Clinical response. J Periodontol 1995; 66:692-699.
40. Ainamo, J, Lie T, Ellingsen BH, et al. Clinical responses to subgingival application of a metronidazole 25-percent gel compared to the effect of subgingival scaling in adult periodontitis. J Clin Periodontol 1992;19:723-729.